261 related articles for article (PubMed ID: 22621777)
1. Tauroursodeoxycholic acid suppresses amyloid β-induced synaptic toxicity in vitro and in APP/PS1 mice.
Ramalho RM; Nunes AF; Dias RB; Amaral JD; Lo AC; D'Hooge R; Sebastião AM; Rodrigues CM
Neurobiol Aging; 2013 Feb; 34(2):551-61. PubMed ID: 22621777
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
[TBL] [Abstract][Full Text] [Related]
3. TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice.
Nunes AF; Amaral JD; Lo AC; Fonseca MB; Viana RJ; Callaerts-Vegh Z; D'Hooge R; Rodrigues CM
Mol Neurobiol; 2012 Jun; 45(3):440-54. PubMed ID: 22438081
[TBL] [Abstract][Full Text] [Related]
4. Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice.
Lo AC; Callaerts-Vegh Z; Nunes AF; Rodrigues CM; D'Hooge R
Neurobiol Dis; 2013 Feb; 50():21-9. PubMed ID: 22974733
[TBL] [Abstract][Full Text] [Related]
5. Gender difference in valproic acid-induced neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer's disease.
Long Z; Zeng Q; Wang K; Sharma A; He G
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):930-938. PubMed ID: 27614317
[TBL] [Abstract][Full Text] [Related]
6. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease.
Antequera D; Bolos M; Spuch C; Pascual C; Ferrer I; Fernandez-Bachiller MI; Rodríguez-Franco MI; Carro E
Neurobiol Dis; 2012 Jun; 46(3):682-91. PubMed ID: 22426395
[TBL] [Abstract][Full Text] [Related]
7. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic mice.
Song Y; Cui T; Xie N; Zhang X; Qian Z; Liu J
Int Immunopharmacol; 2014 May; 20(1):276-81. PubMed ID: 24667368
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
9. Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice.
Wang Y; Tang XC; Zhang HY
J Neurosci Res; 2012 Feb; 90(2):508-17. PubMed ID: 22002568
[TBL] [Abstract][Full Text] [Related]
10. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
[TBL] [Abstract][Full Text] [Related]
11. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
[TBL] [Abstract][Full Text] [Related]
12. L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.
Zhang Y; Huang LJ; Shi S; Xu SF; Wang XL; Peng Y
CNS Neurosci Ther; 2016 Dec; 22(12):979-987. PubMed ID: 27439966
[TBL] [Abstract][Full Text] [Related]
13. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of potassium 2-(l-hydroxypentyl)-benzoate on hippocampal neurons, synapses and dystrophic axons in APP/PS1 mice.
Huang L; Zhang Y; Peng Y; Zhao Z; Zhou Y; Wang X; Peng Y
Psychopharmacology (Berl); 2019 Sep; 236(9):2761-2771. PubMed ID: 31165206
[TBL] [Abstract][Full Text] [Related]
16. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
[TBL] [Abstract][Full Text] [Related]
17. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
Hamilton A; Holscher C
Brain Res; 2012 Apr; 1449():83-93. PubMed ID: 22418058
[TBL] [Abstract][Full Text] [Related]
18. Excitatory synaptic transmission is depressed in cultured hippocampal neurons of APP/PS1 mice.
Priller C; Mitteregger G; Paluch S; Vassallo N; Staufenbiel M; Kretzschmar HA; Jucker M; Herms J
Neurobiol Aging; 2009 Aug; 30(8):1227-37. PubMed ID: 18077058
[TBL] [Abstract][Full Text] [Related]
19. Huntingtin associated protein 1 regulates trafficking of the amyloid precursor protein and modulates amyloid beta levels in neurons.
Yang GZ; Yang M; Lim Y; Lu JJ; Wang TH; Qi JG; Zhong JH; Zhou XF
J Neurochem; 2012 Sep; 122(5):1010-22. PubMed ID: 22731248
[TBL] [Abstract][Full Text] [Related]
20. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
